203 related articles for article (PubMed ID: 20142244)
1. Family history, mammographic density, and risk of breast cancer.
Martin LJ; Melnichouk O; Guo H; Chiarelli AM; Hislop TG; Yaffe MJ; Minkin S; Hopper JL; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):456-63. PubMed ID: 20142244
[TBL] [Abstract][Full Text] [Related]
2. Mammographic densities and risk of breast cancer among subjects with a family history of this disease.
Boyd NF; Lockwood GA; Martin LJ; Knight JA; Jong RA; Fishell E; Byng JW; Yaffe MJ; Tritchler DL
J Natl Cancer Inst; 1999 Aug; 91(16):1404-8. PubMed ID: 10451446
[TBL] [Abstract][Full Text] [Related]
3. Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort.
Maskarinec G; Dartois L; Delaloge S; Hopper J; Clavel-Chapelon F; Baglietto L
Cancer Epidemiol; 2017 Aug; 49():156-160. PubMed ID: 28697417
[TBL] [Abstract][Full Text] [Related]
4. Varying levels of family history of breast cancer in relation to mammographic breast density (United States).
Crest AB; Aiello EJ; Anderson ML; Buist DS
Cancer Causes Control; 2006 Aug; 17(6):843-50. PubMed ID: 16783612
[TBL] [Abstract][Full Text] [Related]
5. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
6. Prenatal and perinatal correlates of adult mammographic breast density.
Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
[TBL] [Abstract][Full Text] [Related]
7. Mammographic features and breast cancer risk: effects with time, age, and menopause status.
Byrne C; Schairer C; Wolfe J; Parekh N; Salane M; Brinton LA; Hoover R; Haile R
J Natl Cancer Inst; 1995 Nov; 87(21):1622-9. PubMed ID: 7563205
[TBL] [Abstract][Full Text] [Related]
8. Body size, mammographic density, and breast cancer risk.
Boyd NF; Martin LJ; Sun L; Guo H; Chiarelli A; Hislop G; Yaffe M; Minkin S
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2086-92. PubMed ID: 17119032
[TBL] [Abstract][Full Text] [Related]
9. Mammographic density as a risk factor for breast cancer in a German case-control study.
Heusinger K; Loehberg CR; Haeberle L; Jud SM; Klingsiek P; Hein A; Bayer CM; Rauh C; Uder M; Cavallaro A; May MS; Adamietz B; Schulz-Wendtland R; Wittenberg T; Wagner F; Beckmann MW; Fasching PA
Eur J Cancer Prev; 2011 Jan; 20(1):1-8. PubMed ID: 21102341
[TBL] [Abstract][Full Text] [Related]
10. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer.
Boyd NF; Martin LJ; Li Q; Sun L; Chiarelli AM; Hislop G; Yaffe MJ; Minkin S
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):961-6. PubMed ID: 16702377
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
12. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.
Malkov S; Shepherd JA; Scott CG; Tamimi RM; Ma L; Bertrand KA; Couch F; Jensen MR; Mahmoudzadeh AP; Fan B; Norman A; Brandt KR; Pankratz VS; Vachon CM; Kerlikowske K
Breast Cancer Res; 2016 Dec; 18(1):122. PubMed ID: 27923387
[TBL] [Abstract][Full Text] [Related]
13. Are breast density and bone mineral density independent risk factors for breast cancer?
Kerlikowske K; Shepherd J; Creasman J; Tice JA; Ziv E; Cummings SR
J Natl Cancer Inst; 2005 Mar; 97(5):368-74. PubMed ID: 15741573
[TBL] [Abstract][Full Text] [Related]
14. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
15. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
16. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer.
Ma H; Luo J; Press MF; Wang Y; Bernstein L; Ursin G
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):479-85. PubMed ID: 19190139
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. Mammographic breast density and family history of breast cancer.
Ziv E; Shepherd J; Smith-Bindman R; Kerlikowske K
J Natl Cancer Inst; 2003 Apr; 95(7):556-8. PubMed ID: 12671024
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332
[TBL] [Abstract][Full Text] [Related]
20. Mammographic breast density as an intermediate phenotype for breast cancer.
Boyd NF; Rommens JM; Vogt K; Lee V; Hopper JL; Yaffe MJ; Paterson AD
Lancet Oncol; 2005 Oct; 6(10):798-808. PubMed ID: 16198986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
